BRD4 is significantly upregulated in HCC patients and in liver cancer cell lines, and the overexpression of BRD4 in cancer tissues is correlated with poor prognosis in HCC patients (Tsang et al., 2019; Zhang et al., 2015). This evidence concerns the gene BRD4 and liver cancer.